Contact
      Please use this form to send email to PR contact of this press release:
      
      Fusion IV Pharmaceuticals INC Examines How Design Methods May Improve During COVID
    
      TO:
      
      Caroline Hunter
      
      Web Presence, LLC
      
      +17862338220